#pbm

GAO Finds Mixed Cost Impacts from Vertically Integrated Medicare PBMs

A new Government Accountability Office report reveals that vertically integrated Medicare Part D plan sponsors directed nearly 28% of pharmacy payments to their own mail-order dispensaries in 2023, yielding lower generic drug costs but higher beneficiary expenses for select high-cost specialty medications.